OncoCyte Corporation (OCX)
NASDAQ: OCX · Real-Time Price · USD
3.060
-0.150 (-4.67%)
At close: Mar 31, 2025, 4:00 PM
3.255
+0.195 (6.36%)
Pre-market: Apr 1, 2025, 4:05 AM EDT
OncoCyte Market Cap
OncoCyte has a market cap or net worth of $87.51 million as of March 31, 2025. Its market cap has increased by 251.46% in one year.
Market Cap
87.51M
Enterprise Value
82.54M
1-Year Change
251.46%
Ranking
Category
Stock Price
$3.06
Market Cap Chart
Since January 4, 2016, OncoCyte's market cap has decreased from $228.70M to $87.51M, a decrease of -61.73%. That is a compound annual growth rate of -9.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 91.80M | 128.93% |
| Dec 31, 2024 | 40.10M | 93.72% |
| Dec 29, 2023 | 20.70M | -45.67% |
| Dec 30, 2022 | 38.10M | -80.96% |
| Dec 31, 2021 | 200.10M | 24.52% |
| Dec 31, 2020 | 160.70M | 37.47% |
| Dec 31, 2019 | 116.90M | 108.38% |
| Dec 31, 2018 | 56.10M | -61.60% |
| Dec 29, 2017 | 146.10M | -27.82% |
| Dec 30, 2016 | 202.40M | -11.50% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.67B |
| UnitedHealth Group | 477.66B |
| Johnson & Johnson | 398.46B |
| AbbVie | 367.15B |
| Novo Nordisk | 305.46B |
| Abbott Laboratories | 228.32B |
| AstraZeneca | 225.46B |
| Merck & Co. | 224.84B |